Vitamin B1 Supplement Recalled for Blister Packaging Defect
Safecor Health is recalling certain Vitamin B1 supplements due to manufacturing defects where blister card-foils are separating from the blister cavity.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall involving a manufacturing defect in product packaging. No illnesses or injuries have been reported. The defect affects packaging integrity but does not involve contamination or immediate safety hazard.
Plain-English summary
Safecor Health, LLC is recalling Vitamin B1, 100 mcg tablets due to a manufacturing defect. Observations revealed that some blister card-foils were separating from the blister cavity, which can affect the integrity of the product packaging.
The affected product was distributed nationwide in the United States. A total of 3,139 boxes were distributed. The recall involves lot numbers 24A0050 (expiration 04/25/2026), 24A0055 (expiration 05/09/2026), 24A0059 (expiration 05/16/2026), 24A0060 (expiration 05/20/2026), 24A0071 (expiration 06/24/2026), and 24A0072 (expiration 06/26/2026). The product is sold through www.safecorhealth.com with NDC 48433-108-01.
The recalled product
- Product
- Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01
- Manufacturer
- Safecor Health, LLC
- Category
- Drug — Vitamin Supplement
- Hazard
- blister-separation
- packaging-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot# 24A0050
- exp. date 04/25/2026
- 24A0055
- exp. date 05/09/2026
- 24A0059
- exp. date 05/16/2026
- 24A0060
- exp. date 05/20/2026
- 24A0071
- exp. date 06/24/2026
- 24A0072
- exp. date 06/26/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27